LYTIR

Company · GDTC

CytoMed Therapeutics Limited

Name as listed on its exchange; filed with the SEC as CytoMed Therapeutics Ltd.

Nasdaq's symbol directory lists GDTC on Nasdaq as “CytoMed Therapeutics Limited - Ordinary Shares”.

In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($429K); 4 filings by holders of 5% or more.

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $429K in total; Insider sales: $0 in total.May: Insider purchases $129KJul: Insider purchases $300KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $429KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. CHOO CHEE KONG bought on 3 days latest Jul 20, 2026 bought $429K
Every trade (3)
  1. BUYCHOO CHEE KONG bought Jul 20, 2026 100,000 shares filing $150K
  2. BUYCHOO CHEE KONG bought Jul 14, 2026 100,000 shares filing $150K
  3. BUYCHOO CHEE KONG bought May 13, 2026 112,000 shares filing $129K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. mDR LTD filed Oct 23, 2026 Schedule 13G/A passive 1,191,523 shares filing 9.98%
  2. Choo Chee Kong filed Oct 16, 2026 Schedule 13D/A may seek influence 3,003,996 shares filing 25.17%
  3. Choo Chee Kong filed Oct 13, 2026 Schedule 13D/A may seek influence 2,974,746 shares filing 24.92%
  4. Choo Chee Kong filed Jul 24, 2026 Schedule 13D/A may seek influence 2,899,746 shares filing 24.3%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.